• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号
首页- Products - Others - Other Targets - PACAP-Related Peptide (PRP), human

PACAP-Related Peptide (PRP), human

CAS No. ——

PACAP-Related Peptide (PRP), human ( —— )

产品货号. M30548 CAS No. ——

PACAP-Related Peptide (PRP), human,a 29 amino-acid region of the PACAP precursor protein, is synthesized in quantities sufficient for biological and structural studies.

纯度: >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
100MG 获取报价 有现货
200MG 获取报价 有现货
500MG 获取报价 有现货
1G 获取报价 有现货

生物学信息

  • 产品名称
    PACAP-Related Peptide (PRP), human
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    PACAP-Related Peptide (PRP), human,a 29 amino-acid region of the PACAP precursor protein, is synthesized in quantities sufficient for biological and structural studies.
  • 产品描述
    PACAP-Related Peptide (PRP), human,a 29 amino-acid region of the PACAP precursor protein, is synthesized in quantities sufficient for biological and structural studies. (In Vitro):PACAP-Related Peptide (PRP) has a distinct biological activity on the gallbladder that is similar to pituitary adenylate cyclase activating polypeptide (PACAP) but opposite to that of vasoactive intestinal polyprptide (VIP); and its related peptide, peptide histidine methlonmc (PHM).
  • 体外实验
    ——
  • 体内实验
    ——
  • 同义词
    ——
  • 通路
    Others
  • 靶点
    Other Targets
  • 受体
    ——
  • 研究领域
    ——
  • 适应症
    ——

化学信息

  • CAS Number
    ——
  • 分子量
    3146.57
  • 分子式
    C139H229N41O42
  • 纯度
    >98% (HPLC)
  • 溶解度
    ——
  • SMILES
    ——
  • 化学全称
    Sequence:Asp-Val-Ala-His-Gly-Ile-Leu-Asn-Glu-Ala-Tyr-Arg-Lys-Val-Leu-Asp-Gln-Leu-Ser-Ala-Gly-Lys-His-Leu-Gln-Ser-Leu-Val-Ala

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

Wray V, et al. Synthesis, solution structure and biological action of PACAP-related peptide. Biomed Pept Proteins Nucleic Acids. 1995;1(2):77-82.
产品手册
关联产品
  • NFATc1-IN-1

    NFATc1-IN-1 (compound A04) 一种是 RANKL- 诱导的破骨细胞 (osteoclast) 形成的有效抑制剂,其 IC50 为 1.57 μM。NFATc1-IN-1 通过降低 RANKL 诱导的 NFATc1 核转位,显示抗破骨细胞 (anti-osteoclastogenic) 作用。NFATc1-IN-1 可用于破骨疾病的研究。

  • Transduction Peptide...

    Transduction Peptide 1 (α II)

  • NBMPR

    Nitrobenzylthioinosine 是 ENT1 转运蛋白的抑制剂,以高亲和力与 ENT1 转运蛋白结合。